GENE ONLINE|News &
Opinion
Blog

Treatment
GeneOnline’s Weekly News Highlights: Aug 21-25
2023-08-28
Introducing Veopoz™: A Breakthrough Treatment for CHAPLE Disease
2023-08-28
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
Finding new pharmacological approach for neuroblastoma treatment
2018-10-16
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top